Activation of Krox20 gene expression by Sox10 in myelinating Schwann cells

Journal of Neurochemistry

Volumn 112, Issue 3, 2010, Pages 744-754

  Reiprich, Simone ^a   Kriesch, Jana ^a   Schreiner, Silke ^a   Wegner, Michael ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Glia; High mobility group; Neural crest; Peripheral nervous system; POU; Transcription factor

Indexed keywords

OCTAMER TRANSCRIPTION FACTOR 6; TRANSCRIPTION FACTOR SOX10;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DNA BINDING; GENE EXPRESSION; GLIA; MYELINATION; NEURAL CREST; NONHUMAN; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; PROTEIN DOMAIN; RAT; SCHWANN CELL; WESTERN BLOTTING;

ANIMALS; BINDING SITES; CELL LINE, TRANSFORMED; EARLY GROWTH RESPONSE PROTEIN 2; ELECTROPHORETIC MOBILITY SHIFT ASSAY; EMBRYO, MAMMALIAN; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; MICE; MICE, TRANSGENIC; MUTATION; ORGANIC CATION TRANSPORT PROTEINS; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; SCHWANN CELLS; SOXE TRANSCRIPTION FACTORS; TRANSFECTION;

EID: 73949157430     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2009.06498.x     Document Type: Article

References (33)

1. Bondurand N., Girard M., Pingault V., Lemort N., Dubourg O. Goossens M. (2001) Human Connexin 32, a gap junction protein altered in the X-linked form of Charcot-Marie-Tooth disease, is directly regulated by the transcription factor SOX10. Hum. Mol. Genet. 10, 2783 2795.
2. Britsch S., Goerich D. E., Riethmacher D., Peirano R. I., Rossner M., Nave K. A., Birchmeier C. Wegner M. (2001) The transcription factor Sox10 is a key regulator of peripheral glial development. Genes Dev. 15, 66 78.
3. Friedrich R., Schlierf B., Tamm E. R., Bösl M. R. Wegner M. (2005) The class III POU domain protein Brn-1 can fully replace the related Oct-6 during Schwann cell development and myelination. Mol. Cell. Biol. 25, 1821 1829.
4. Ghislain J. Charnay P. (2006) Control of myelination in Schwann cells: a Krox20 cis-regulatory element integrates Oct6, Brn2 and Sox10 activities. Embo Rep. 7, 52 58.
5. Ghislain J., Desmarquet-Trin-Dinh C., Jaegle M., Meijer D., Charnay P. Frain M. (2002) Characterisation of cis-acting sequences reveals a biphasic, axon-dependent regulation of Krox20 during Schwann cell development. Development 129, 155 166.
6. Harley V. R., Lovell-Badge R. Goodfellow P. N. (1994) Definition of a consensus DNA binding site for SRY. Nucleic Acids Res. 22, 1500 1501.
7. Jaegle M., Ghazvini M., Mandemakers W., Piirsoo M., Driegen S., Levavasseur F., Raghoenath S., Grosveld F. Meijer D. (2003) The POU proteins Brn-2 and Oct-6 share important functions in Schwann cell development. Genes Dev. 17, 1380 1391.
8. Jessen K. R. Mirsky R. (2005) The origin and development of glial cells in peripheral nerves. Nat. Rev. Neurosci. 6, 671 682.
9. Jones E. A., Jang S. W., Mager G. M., Chang L. W., Srinivasan R., Gokey N. G., Ward R. M., Nagarajan R. Svaren J. (2007) Interactions of Sox10 and Egr2 in myelin gene regulation. Neuron Glia Biol. 3, 377 387.
10. Kamachi Y., Uchikawa M. Kondoh H. (2000) Pairing SOX off: with partners in the regulation of embryonic development. Trends Genet. 16, 182 187.
11. Kao S. C., Wu H., Xie J., Chang C. P., Ranish J. A., Graef I. A. Crabtree G. R. (2009) Calcineurin/NFAT signaling is required for neuregulin-regulated Schwann cell differentiation. Science 323, 651 654.
12. Kellerer S., Schreiner S., Stolt C. C., Bösl M. R. Wegner M. (2006) Functional equivalency of transcription factors Sox8 and Sox10 is tissue-specific. Development 133, 2875 2886.
13. Kuhlbrodt K., Herbarth B., Sock E., Hermans-Borgmeyer I. Wegner M. (1998a) Sox10, a novel transcriptional modulator in glial cells. J. Neurosci. 18, 237 250.
14. Kuhlbrodt K., Schmidt C., Sock E., Pingault V., Bondurand N., Goossens M. Wegner M. (1998b) Functional analysis of Sox10 mutations found in human Waardenburg-Hirschsprung patients. J. Biol. Chem. 273, 23033 23038. (Pubitemid 28417482)
15. Le N., Nagarajan R., Wang J. Y., Araki T., Schmidt R. E. Milbrandt J. (2005) Analysis of congenital hypomyelinating Egr2Lo/Lo nerves identifies Sox2 as an inhibitor of Schwann cell differentiation and myelination. Proc. Natl. Acad. Sci. USA 102, 2596 2601.
16. LeBlanc S. E., Ward R. M. Svaren J. (2007) Neuropathy-associated Egr2 mutants disrupt cooperative activation of myelin protein zero by Egr2 and Sox10. Mol. Cell. Biol. 27, 3521 3529.
17. Ludwig A., Rehberg S. Wegner M. (2004) Melanocyte-specific expression of dopachrome tautomerase is dependent on synergistic gene activation by the Sox10 and Mitf transcription factors. FEBS Lett. 556, 236 244.
18. Maka M., Stolt C. C. Wegner M. (2005) Identification of Sox8 as a modifier gene in a mouse model of Hirschsprung disease reveals underlying molecular defect. Dev. Biol. 277, 155 169.
19. Nagarajan R., Svaren J., Le N., Araki T., Watson M. Milbrandt J. (2001) EGR2 mutations in inherited neuropathies dominant-negatively inhibit myelin gene expression. Neuron 30, 355 368.
20. Peirano R. I., Goerich D. E., Riethmacher D. Wegner M. (2000) Protein zero expression is regulated by the glial transcription factor Sox10. Mol. Cell. Biol. 20, 3198 3209.
21. Remenyi A., Lins K., Nissen L. J., Reinbold R., Schöler H. R. Wilmanns M. (2003) Crystal structure of a POU/HMG/DNA ternary complex suggests differential assemby of Oct4 and Sox2 on two enhancers. Genes Dev. 17, 2048 2059.
22. Renner K., Leger H. Wegner M. (1994) The POU-domain protein Tst-1 and papovaviral T-antigen function synergistically to stimulate glia-specific gene expression of JC virus. Proc. Natl Acad. Sci. USA 91, 6433 6437.
23. Schlierf B., Ludwig A., Klenovsek K. Wegner M. (2002) Cooperative binding of Sox10 to DNA: requirements and consequences. Nucleic Acids Res. 30, 5509 5516.
24. Schreiber J., Enderich J., Sock E., Schmidt C., Richter-Landsberg C. Wegner M. (1997) Redundancy of class III POU proteins in the oligodendrocyte lineage. J. Biol. Chem. 272, 32286 32293.
25. Schreiner S., Cossais F., Fischer K., Scholz S., Bösl M. R., Holtmann B., Sendtner M. Wegner M. (2007) Hypomorphic Sox10 alleles reveal novel protein functions and unravel developmental differences in glial lineages. Development 134, 3271 3281.
26. Sock E., Enderich J., Rosenfeld M. G. Wegner M. (1996) Identification of the nuclear localization signal of the POU domain protein Tst-1/Oct6. J. Biol. Chem. 271, 17512 17518.
27. Sock E., Pagon R. A., Keymolen K., Lissens W., Wegner M. Scherer G. (2003) Loss of DNA-dependent dimerization of the transcription factor SOX9 as a cause for campomelic dysplasia. Hum. Mol. Genet. 12, 1439 1447.
28. Stolt C. C., Lommes P., Sock E., Chaboissier M.-C., Schedl A. Wegner M. (2003) The Sox9 transcription factor determines glial fate choice in the developing spinal cord. Genes Dev. 17, 1677 1689.
29. Topilko P., Schneider M. S., Levi G., Baron V. E. A., Chennoufi A. B., Seitanidou T., Babinet C. Charnay P. (1994) Krox-20 controls myelination in the peripheral nervous system. Nature 371, 796 799.
30. Wegner M. (1999) From head to toes: the multiple facets of Sox proteins. Nucleic Acids Res. 27, 1409 1420.
31. Wegner M. (2005) Secrets to a healthy Sox life: Lessons for melanocytes. Pigment Cell Res. 18, 74 85.
32. Wegner M. (2009) All purpose Sox: the many roles of Sox proteins in gene expression. Int. J. Biochem. Cell Biol. doi :.
33. Wißmüller S., Kosian T., Wolf M., Finzsch M. Wegner M. (2006) The High-mobility-group domain of Sox proteins interacts with the DNA-binding domains of many transcription factors. Nucleic Acids Res. 34, 1735 1744.